D Alarcon Segovia

Summary

Country: Mexico

Publications

  1. ncbi Prophylaxis of the antiphospholipid syndrome: a consensus report
    D Alarcon-Segovia
    Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico DF, Mexico
    Lupus 12:499-503. 2003
  2. ncbi The future of treatment for systemic lupus erythematosus
    D Alarcon-Segovia
    Department of Immunology and Rheumatology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico
    Isr Med Assoc J 3:127-30. 2001
  3. ncbi Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus
    A R Cabral
    Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
    Lupus 13:182-7. 2004
  4. ncbi Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus
    M Valencia-Flores
    Departamento de Neurologia y Psiquiatra, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Delegacion Tlalpan, Mexico 14000, DF, Mexico
    Lupus 13:4-10. 2004

Collaborators

Detail Information

Publications5

  1. ncbi Prophylaxis of the antiphospholipid syndrome: a consensus report
    D Alarcon-Segovia
    Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico DF, Mexico
    Lupus 12:499-503. 2003
    ..In no instance should corticosteroids or immunosuppresants be given as prophylactic of an antiphospholipid syndrome...
  2. ncbi The future of treatment for systemic lupus erythematosus
    D Alarcon-Segovia
    Department of Immunology and Rheumatology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico
    Isr Med Assoc J 3:127-30. 2001
    ..All these treatment strategies will gradually become decanted in order to achieve the optimal treatment of SLE, which may tum out to be its cure...
  3. ncbi Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus
    A R Cabral
    Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
    Lupus 13:182-7. 2004
    ..In contrast, anti-beta2GP1 from patients with APS(+)/aPL(-) are blocked by cardiolipin, suggesting that their epitope is the phospholipid-binding site...
  4. ncbi Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus
    M Valencia-Flores
    Departamento de Neurologia y Psiquiatra, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Delegacion Tlalpan, Mexico 14000, DF, Mexico
    Lupus 13:4-10. 2004
    ..Fibromyalgia is not common in Mexican patients with SLE and has a different pattern of symptoms in RP and NP patients. These data add evidence that ethnicity can play an important role in FM manifestations...